Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach

Older chronic lymphocytic leukemia patients have poor outcomes with standard treatments and are underrepresented in clinical trials. We retrospectively reviewed outcomes of refractory chronic lymphocytic leukemia patients in two age categories (≥70 and <70 years) treated with single-agent flavopi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stephens, Deborah M., Ruppert, Amy S., Blum, Kristie, Jones, Jeffrey, Flynn, Joseph M., Johnson, Amy J., Ji, Jia, Phelps, Mitch A., Grever, Michael R., Byrd, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2012
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3291598/
https://ncbi.nlm.nih.gov/pubmed/22271900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.047324
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados